RFPを含む3方式による肺結核6ヵ月化療の対照試験 (第1報)
スポンサーリンク
概要
- 論文の詳細を見る
This investigation was designed to find out the 6 months regimen of chemotherapy which is expected to be most effective with less adverse reactions and least relapse rate.<BR>The patients were chosen from those admitted to the National Nakano Chest Hospital in October 1975 and thereafter. Smear positive cases of pulmonary tuberculosis with cavity less than 4cm in diameter or without cavity, who were previously untreated or had been treated for less than 15 days were subjected to the study.<BR>They were allocated at random to the following 3 regimens; A) RHS daily 3m.→RH daily S<SUB>2</SUB> 3m., B) RHZS daily 2m.→RHZ daily 4m., C) RHZE daily 2m.→RHZ daily 4m. Drug sensitivity tests were done by Canettis proportion method. Criteria for sensitivity was less than 50% to 10 mcg or 1% to 50 mcg RFP, less than 1% to SM 10mcg, INH 0.2mcg and EB 3mcg.<BR>By the end of February 1977, 113 cases have completed the 6 months chemotherapy, and 7 cases were excluded due to reasons cited in Tab. 1. The remaining 106 cases were divided into 2 categories, one completed the fixed regimen and the other in which the regimen was changed, but in all cases, the duration of chemotherapy was fixed to 6 months.<BR>All 106 cases became culture negative by the end of the 4 th month of chemotherapy, and the negative conversion took place much faster in regimen B than in regimen A (Fig. 2), and it was similar even in the aged patients and cases complicated with diabetes. The negative conversion occured much faster in this study subject than any other previous cases treated with regimens without RFP.<BR>Adverse reactions were seen most frequently in regimen B, then in C and least in A (Tab. 3) Among them, those attributable to SM and PZA were found to be most frequent. Those due to SM were allergic reactions, tinnitus and dizziness, and those due to PZA were liver dysfunction and gastrointestinal disturbances. They occured especially frequently during the first 3 months. Even though the X-ray shadow and cavity were still unstable at the end of 6 months chemotherapy, they continued to improve after stopping the chemotherapy as if they were treated continuously (Tab.2 and 6).<BR>No bacteriological relapse was seen up to the end of February, 1977, but as the observation period after stopping the chemotherapy was still short, we are following up these cases carefully.<BR>It is our regret that there are some doctors who started again an additional chemotherapy for cases who completed the 6 months chemotherapy in our hospital. The reason for restarting chemotherapy was unstable X-ray findings, and the result of bacteriological findings were disregarded by these doctors.
- 日本結核病学会の論文
著者
関連論文
- 外来性再感染によると思われる4症例について-4-総括,討論,結論
- 外来性再感染によると思われる4症例について-3-症例4および症例2,3,4の相互関連その他の検討
- 外来性再感染によると思われる4症例について-2-症例3について
- 外来性再感染によると思われる4症例について-1-症例1および症例2について
- 結核性膿胸患者の治療に関する研究
- 燒灼336名について
- 癌性胸膜炎に対する胸膜生検の診断的意義
- ^Hg : グルタチオンによる肺癌シンチグラフィーの臨床的価値
- 肺癌の放射性第2塩化水銀のマクロオートラジオグラムと組織変化の検討 : 関東支部 : 第39回支部活動
- 11.肺癌における放射性水銀の診断的価値 : 第37回支部会 : 関東支部
- RFPを含む3方式による肺結核6ヵ月化療の対照試験 (第2報) : 治療終了後1年目の成績
- RFPを含む3方式による肺結核6ヵ月化療の対照試験 (第1報)
- 外来性再感染によると思われる4症例について : 第4部総括, 討論, 結論
- 外来性再感染によると思われる4症例について : 第3部 症例4および症例2, 3, 4の相互関連その他の検討
- 外来性再感染によると思われる4症例について : 第2部症例3について
- 外来性再感染によると思われる4症例について : 第1部症例1および症例2について
- 一次薬3者併用におけるSM毎日と週2回の比較 : 特に耐性限界を考慮して (第2報)
- RFPの耐性 (後編)
- RFPの耐性 (前編)
- 次薬3者併用におけるSM毎日と週2回の比較 : ―特に耐性限界を考慮しで(第1報)―
- SM, INH, PASの臨床耐性限界
- 抗結核剤の1回および分服法の比較
- Rifampicinによる肺結核の再治療
- Rifampicinによる肺結核の再治療
- Ethambutolによる視力障害
- D-2,2-(Ethylenediimino)di-1-butanol[Ethambutol, Ebutol]の臨床成績
- D-2, 2-(Ethylenediimino)di-1-butanol[Ethambutol,Ebuto1]の臨床成績
- 糖尿病合併肺結核患者の末梢血白血球によるBCG食菌作用
- エタンブトールの体内分布とその代謝